A 59-year-old man with type 2 diabetes mellitus presents to the nurse practitioner with complaints of reduced libido, weight gain, and depression. His most recent HgbA1C is 7.9, and he scored 4 on the PHQ-9. Which of the following is the most appropriate at this time?

Choice A reason: Bupropion is an antidepressant that may improve energy and libido, but the PHQ-9 score of 4 indicates minimal depressive symptoms. The primary concern here is reduced libido and weight gain, which may be better addressed by evaluating testosterone levels. Choice B reason: Testosterone deficiency is common in men with type 2 diabetes and can contribute to reduced libido, weight gain, and mood changes. Given the low PHQ-9 score and symptoms suggestive of hypogonadism, testosterone replacement therapy is the most appropriate next step after confirming low serum testosterone levels. Choice C reason: Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) used for depression. However, SSRIs can further reduce libido and are not indicated for mild depressive symptoms. This choice does not address the patient's primary concerns. Choice D reason: Dulaglutide is a GLP-1 receptor agonist used to improve glycemic control and promote weight loss. While it may help with weight, it does not address libido or mood directly and is not the most targeted intervention for the current symptoms.